5-NITRO-1,2,3,4-TETRAHYDROQUINOLINE, 95.0%, 250mg

3,3-Dimethyl-2,3-dihydropyran-4-one, 95.0%, 100mg

potassium 4-isopropyl-1,3-thiazole-2-carboxylate, 95.0%, 5g

4-((3-Chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl acetate, 97.0%, 100mg

2',3',5'-Tri-O-acetyl, 95.0%, 500g

4-(Azetidin-1-ylmethyl)benzonitrile, 95%, 5g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket GL connecting piece, DN 60, 250 ml, 90 mm, 1 Piece

N,N'-((1S,2S)-Cyclohexane-1,2-diyl)dipicolinamide, 95.0%, 10g

3,3'-Diaminobenzidine>98.0%(HPLC)5g

2,4-Dinonylphenol (mixture of isomers), 5g

Ethyl 2-Cyano-2-methylpropionate>98.0%(GC)25g

2-Bromo-5-chlorophenylacetic acid, 98.0%, 100g

(7-(6-Aminopyridin-3-yl)-2,3-dihydrobenzo[f][1,4]oxazepin-4(5H)-yl)(3-fluoro-2-methyl-4-(methylsulfonyl)phenyl)methanone, 98%, 50mg